Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Kathrin Meyer

Assistant Professor

Ohio State University

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

40%

Tissue Engineering

40%

Gene Therapy

40%

Autophagy

30%

Cell Therapy

30%

Glia

30%

Neurodegenerative Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

MeCP2 gene therapy ameliorates disease phenotype in mouse model for Pitt Hopkins syndrome

Article Link

Year:

2024

The postnatal injection of AAV9-FOXG1 rescues corpus callosum agenesis and other brain deficits in the mouse model of FOXG1 syndrome

Article Link

Year:

2024

In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans

Article Link

Year:

2023

In Vitro Modeling as a Tool for Testing Therapeutics for Spinal Muscular Atrophy and IGHMBP2-Related Disorders.

Article Link

Year:

2023

Opportunities for mitochondrial disease gene therapy.

Article Link

Year:

2023

Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease.

Article Link

Year:

2023

Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure-ANVIAS Study.

Article Link

Year:

2023

AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models.

Article Link

Year:

2023

Editorial: Personalized medicine for neuromuscular disorders.

Article Link

Year:

2023

CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosis.

Article Link

Year:

2022

PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD.

Article Link

Year:

2022

EphA4 targeting agents protect motor neurons from cell death induced by amyotrophic lateral sclerosis -astrocytes.

Article Link

Year:

2022

Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV.

Article Link

Year:

2022

Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes.

Article Link

Year:

2022

Emerging Perspectives on Gene Therapy Delivery for Neurodegenerative and Neuromuscular Disorders

Article Link

Year:

2022

Collaborators14

Carlo Baggio

University of California, Riverside

UNITED STATES

Olivier Scheidegger

SWITZERLAND

Stephen J Kolb

The Ohio State University Wexner Medical Center

UNITED STATES

Julieth Sierra-Delgado

Assistant Research Professor

University of Missouri

UNITED STATES

Nitin Chakravarti

Assistant Professor

Thomas Jefferson University

UNITED STATES

priyanka tripathi

University of Maastricht

NETHERLANDS

Iryna Ethell

UNITED STATES

Bhuvaneish Thangaraj Selvaraj

University of Edinburgh

UNITED KINGDOM

Dora Brites

Senior Researcher and Invited Full Professor

Universidade de Lisboa Faculdade de Farmácia

PORTUGAL

Nicolas Wein

Assistant Professor

Nationwide Children's Hospital

UNITED STATES

Meisam Naeimi Kararoudi

Research Assistant Professor

Ohio State University

UNITED STATES

Soo-Kyung Lee

Professor

University at Buffalo - North Campus

UNITED STATES

Maria Clara Franco

Associate Professor (tenured)

Florida International University

UNITED STATES

Ana Rita Vaz

Professor Auxiliar

Universidade de Lisboa Faculdade de Farmácia

PORTUGAL

How do I reach out?

Meet Kite AI